Newsletter
We 💜Events, Drugs 💊 Rarebase & NOSpharma, Data 👩🏾‍💻 Simons & Invitae #S10e75

SYNGAP10

We 💜Events, Drugs 💊 Rarebase & NOSpharma, Data 👩🏾‍💻 Simons & Invitae #S10e75

GLOBAL GENES WAS GREAT Panel was impressive, will be sharing when recording is live, one point was small molecules…#GlobalGenes #CareAboutRareEVENTS ARE COMING 3 weeks! October 8 in NJ - Caren…
September 18, 2022

We 💜Events, Drugs 💊 Rarebase & NOSpharma, Data 👩🏾‍💻 Simons & Invitae #S10e75

GLOBAL GENES WAS GREAT

Panel was impressive, will be sharing when recording is live, one point was small molecules…
#GlobalGenes #CareAboutRare

EVENTS ARE COMING

3 weeks!
October 8 in NJ – Caren Leib Gala https://www.syngapresearchfund.org/get-involved/fundraising/caren-leib-gala October 8 in SC – Scramble for SYNGAP https://www.syngapresearchfund.org/get-involved/fundraising/scramble-for-syngap

8 weeks!
November 12 in GA – Sparks of Hope Gala https://syngap.fund/soiree

11 weeks!
December 1 in TN – Syngap Science Meeting – https://syngap.fund/treat

RAREBASE

Talked about this in #s10e27 https://youtu.be/r3bS9YepQ4s

We are investing in small molecule repurposing as fast as we can.  Four lines…

Cannonball 2.0 is on!  Checkout UFDtech on 21 October 2022!

LINK#UFDtech #CannonballForTheCure #RareBase

NOSPHARMA

Talked about Bowie in #s10e69 https://www.youtube.com/watch?v=xl_r4hoDlf8

Nospharma leverages unique biological causes of brain disorders within the context of what is already known, to deliver effective treatments. By placing biology-first, we’ve created new drugs and repurposed on-the-market drugs to improve treatment success.  We aim to deliver the most effective therapeutics for some of the most severe brain disorders, as quickly as possible.
…from https://www.linkedin.com/company/nospharma/
#NOSpharma 

SIMONS/INVITAE PARTNERSHIP

Two of the most important players in the Rare Epilepsy Ecosystem are partnering and it’s great news for SYNGAP1 and SRF.
https://www.prnewswire.com/news-releases/invitae-and-simons-searchlight-partner-to-accelerate-research-through-data-sharing-301621469.html
Tweet: https://twitter.com/cureSYNGAP1/status/1569326298790789122
#SimonsFoundation #Autism #Invitae #ciitizen

Satterstrom paper associates SYNGAP1 with Autism strongly
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250485/
See figure 2B https://pubmed.ncbi.nlm.nih.gov/31981491/#&gid=article-figures&pid=figure-2-uid-1

AUTISM BRAIN NETWORK

Webinar: https://www.syngapresearchfund.org/webinars/an-introduction-to-autism-brainnet Site: https://www.autismbrainnet.org/ 

etc.

This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast 

Apple podcasts: https://syngap.fund/10a

 

Episode 75 of Syngap10 – September 18, 2022 

 

#Syngap #SYNGAP1 #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology

ADVERTISEMENT
ADVERTISEMENT

You may also like

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Silver Sponsors

Bronze Sponsors

Event and Media Partners

Buffer LinkedIn WhatsApp